All Releases
View Summary Celldex Presents Varlilumab Proof of Concept Data at SITC Annual Meeting 2014
Nov 7, 2014
PDF 29.4 KB Add to Briefcase
View Summary Celldex Reports Third Quarter 2014 Results
Nov 4, 2014
PDF 39.2 KB Add to Briefcase
View Summary Celldex Therapeutics Announces Upcoming Presentations of Rindopepimut Data at 19th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO)
Nov 3, 2014
PDF 27.6 KB Add to Briefcase
View Summary Celldex Announces Publication of Glembatumumab Vedotin Phase 1/2 Studies in the Journal of Clinical Oncology
Sep 30, 2014
PDF 36.8 KB Add to Briefcase
View Summary Celldex Therapeutics Initiates Pilot Study of CDX-301 in Allogeneic Hematopoietic Stem Cell Transplantation
Sep 25, 2014
PDF 27.9 KB Add to Briefcase
View Summary Celldex Announces Upcoming Presentation at the Morgan Stanley Healthcare Conference
Sep 3, 2014
PDF 21.4 KB Add to Briefcase
View Summary Celldex Reports Second Quarter 2014 Results
Aug 6, 2014
PDF 40.2 KB Add to Briefcase
View Summary Celldex Therapeutics Announces Senior Leadership Promotions
Jul 30, 2014
PDF 31.0 KB Add to Briefcase
View Summary Celldex to Report Second Quarter 2014 Financial Results and Host Corporate 2014 Objectives Update Call
Jul 18, 2014
PDF 22.3 KB Add to Briefcase
View Summary Celldex Therapeutics' Varlilumab Continues to Demonstrate Very Favorable Profile
Jun 2, 2014
PDF 34.0 KB Add to Briefcase
View Summary Oncothyreon and Celldex Therapeutics Announce Collaboration for Combination Immunotherapy Clinical Trial of ONT-10 and Varlilumab
May 29, 2014
PDF 20.9 KB Add to Briefcase
View Summary Celldex Therapeutics to Present at the Jefferies 2014 Global Healthcare Conference
May 28, 2014
PDF 26.1 KB Add to Briefcase
View Summary Celldex Therapeutics Announces Varlilumab (CDX-1127) Phase 1 Clinical Data to be Presented at ASCO Annual Meeting 2014
May 14, 2014
PDF 28.1 KB Add to Briefcase
View Summary Bristol-Myers Squibb and Celldex Therapeutics Announce Clinical Trial Collaboration to Evaluate the Combination of Investigational Immunotherapies Nivolumab and Varlilumab
May 14, 2014
PDF 25.6 KB Add to Briefcase
View Summary Celldex to Present at Two Upcoming Investor Conferences
May 2, 2014
PDF 22.1 KB Add to Briefcase
View Summary Celldex Reports First Quarter 2014 Results
May 1, 2014
PDF 27.8 KB Add to Briefcase
View Summary Celldex's Phase 1 Study of CDX-1401 Published in Science Translational Medicine
Apr 16, 2014
PDF 24.2 KB Add to Briefcase
View Summary Celldex Therapeutics Establishes Preclinical Proof of Concept for New Antibody Drug Conjugate CDX-014; Data presented at AACR 2014
Apr 7, 2014
PDF 19.1 KB Add to Briefcase
View Summary Celldex Therapeutics to Present Antibody-Drug Conjugate CDX-014 Preclinical Proof of Concept Data at AACR 2014
Apr 3, 2014
PDF 15.0 KB Add to Briefcase
View Summary Celldex Reports Fiscal 2013 Business/Financial Results and Outlines 2014 Strategy
Mar 3, 2014
PDF 35.0 KB Add to Briefcase
Showing 61-80 of 140 Page: 1 2 3 4 5 6 7  Previous 20 | Next 20
Showing 61-80 of 140
Page: 1 2 3 4 5 6 7
 Previous 20 | Next 20
Add to Briefcase = add release to Briefcase